Severe Renal Arteriosclerosis in Lupus Nephritis Predicts ASCVD
Severe renal arteriosclerosis in diagnostic lupus nephritis biopsies is associated with 9-fold higher odds of atherosclerotic cardiovascular disease.
Atherosclerosis
AHA Scientific Statement on Prevention of CVD Risk During Menopause Transition
Scientific statement by AHA detailing the current understanding of menopause transition and its impact on the risk for postmenopausal cardiovascular disease.
ACC Consensus Decision Pathway for Anticoagulant, Antiplatelet Use in Patients With AF or VTE Scheduled for PCI
Expert consensus decision pathway for anticoagulant and antiplatelet use in patients with atherosclerotic cardiovascular disease or in those with atrial fibrillation or venous thromboembolism undergoing percutaneous coronary intervention.
A Closer Look at Cardiovascular Disease Risk in Patients With Systemic Lupus Erythematosus
An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.
Atherosclerosis Better Predictor of Future Cardiovascular Events Than Stenosis
Results of this study contradict the currently held paradigm of stenosis-related CVD risk.
Elevated VCAM-1 Levels Associated With Long-Term Risk of Heart Failure
VCAM-1 has been implicated in the pathogenesis of heart failure with preserved ejection fraction (HFpEF), but what is the association of VCAM-1 with development of clinically overt heart failure (HF) across ejection fraction categories?
Coronary Atherosclerotic Plaque Characteristics for Coronary Artery Disease Prognosis
The presence of calcified coronary atherosclerotic plaque morphology was found to predict all-cause and cardiovascular mortality among patients with coronary artery disease.
Periodontal Pathogens Linked to Atherosclerosis in RA
For patients with rheumatoid arthritis (RA), immunoreactivity against Aggregatibacter actinomycetemcomitans serotype b (anti-Aa) and Aa leukotoxin A (anti-LtxA) is associated with atherosclerosis.
Update on Lipid-Lowering Therapies for CVD
Atherosclerotic cardiovascular disease represents the top global cause of morbidity and mortality.
Elevated LDL-C Associated With Higher Risk for MI, Atherosclerotic CVD in People Ages 70 to 100 Years
Elevated LDL-C levels in people ages 70 to 100 years were found to be associated with a higher absolute risk for myocardial infarction and atherosclerotic cardiovascular disease.
- Loading...
Loading...
Next post in Dyslipidemia
Loading... 
Loading...